Abstract
For over 40 years, scientists have endeavored to understand the so-called sigma receptors. During this time, the concept of sigma receptors has continuously and significantly evolved. With thousands of publications on the subject, these proteins have been implicated in various diseases, disorders, and physiological processes. Nevertheless, we are just beginning to understand what sigma proteins do and how they work. Two subtypes have been identified, Sigma1 and Sigma2. Whereas Sigma1 (also known as sigma-1 receptor, Sig1R, σ1 receptor, and several other names) was cloned over 20 years ago, Sigma2 (sigma-2 receptor, σ2 receptor) was cloned very recently and had remained a pharmacologically defined entity. In this volume, we will focus primarily on Sigma1. We will highlight several key subject areas in which Sigma1 has been well characterized as well as (re)emerging areas of interest. Despite the large number of publications regarding Sigma1, several fundamental questions remain unanswered or only partially answered. Most of what we know about Sigma1 comes from pharmacological studies; however, a clearly defined molecular mechanism of action remains elusive. One concept has become clear; Sigma1 is not a traditional receptor. Sigma1 is now considered a unique pharmacologically regulated integral membrane chaperone or scaffolding protein. A number of landmark discoveries over the past decade have begun to reshape the concept of sigma receptors. With the rapid emergence of new information, development of new tools, and changing conceptual frameworks, the field is poised for a period of accelerated progress.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alon A, Schmidt HR, Wood MD, Sahn JJ, Martin SF, Kruse AC (2017) Identification of the gene that codes for the sigma2 receptor. Proc Natl Acad Sci U S A 114:7160. https://doi.org/10.1073/pnas.1705154114
Bartz F, Kern L, Erz D, Zhu M, Gilbert D, Meinhof T, Wirkner U, Erfle H, Muckenthaler M, Pepperkok R, Runz H (2009) Identification of cholesterol-regulating genes by targeted RNAi screening. Cell Metab 10(1):63–75. https://doi.org/10.1016/j.cmet.2009.05.009
Cho TS, Avidan S, Freeman WT (2010) A probabilistic image jigsaw puzzle solver. In: Computer vision and pattern recognition 2010 I.E. conference, pp 183–190. doi:https://doi.org/10.1109/CVPR.2010.5540212
Cobos EJ, Entrena JM, Nieto FR, Cendán CM, Del Pozo E (2008) Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol 6(4):344–366
Gromek KA, Suchy FP, Meddaugh HR, Wrobel RL, LaPointe LM, Chu UB, Primm JG, Ruoho AE, Senes A, Fox BG (2014) The oligomeric states of the purified sigma-1 receptor are stabilized by ligands. J Biol Chem 289(29):20333–20344. https://doi.org/10.1074/jbc.M113.537993
Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 93(15):8072–8077
Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131(3):596–610
Hellewell SB, Bowen WD (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527(2):244–253
Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR (2017) A role for sigma receptors in stimulant self-administration and addiction. Handb Exp Pharmacol. https://doi.org/10.1007/164_2016_94
Kim FJ, Maher CM (2017) Sigma1 pharmacology in the context of cancer. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_38
Kim FJ, Pasternak GW (2017) Cloning the sigma2 receptor: wandering 40 years to find an identity. Proc Natl Acad Sci U S A 114(27):6888–6890. https://doi.org/10.1073/pnas.1708155114
Kourrich S (2017) Sigma-1 receptor and neuronal excitability. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_8
Kruse A (2016) Structural insights into Sigma1 function. Handb Exp Pharmacol. https://doi.org/10.1007/164_2016_95
Laurini E, Col VD, Mamolo MG, Zampieri D, Posocco P, Fermeglia M, Vio L, Pricl S (2011) Homology model and docking-based virtual screening for ligands of the σ1 receptor. ACS Med Chem Lett 2(11):834–839. https://doi.org/10.1021/ml2001505
Laurini E, Marson D, Fermeglia M, Pricl S (2017) 3D homology model of Sigma1 receptor. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_35
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197(3):517–532
Maurice T, Goguadze N (2017) Sigma-1 (sigma1) receptor in memory and neurodegenerative diseases. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_15
Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124(2):195–206
Merlos M, Romero L, Zamanillo D, Plata-Salaman C, Vela JM (2017) Sigma-1 receptor and pain. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_9
Narayanan S, Bhat R, Mesangeau C, Poupaert JH, McCurdy CR (2011) Early development of sigma-receptor ligands. Future Med Chem 3(1):79–94. https://doi.org/10.4155/fmc.10.279
Ortega-Roldan JL, Ossa F, Amin NT, Schnell JR (2015) Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor. FEBS Lett 589(5):659–665. https://doi.org/10.1016/j.febslet.2015.01.033
Pasternak GW (2017) Allosteric modulation of opioid G-protein coupled receptors by Sigma1 receptors. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_34
Sabino V, Cottone P (2016) Sigma receptors and alcohol use disorders. Handb Exp Pharmacol. https://doi.org/10.1007/164_2016_97
Schmidt HR, Zheng S, Gurpinar E, Koehl A, Manglik A, Kruse AC (2016) Crystal structure of the human sigma receptor. Nature 532:527. https://doi.org/10.1038/nature17391
Su TP (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223(2):284–290
Weber F, Wunsch B (2017) Medicinal chemistry of sigma1 receptor ligands: pharmacophore models, synthesis, structure affinity relationships, and pharmacological applications. Handb Exp Pharmacol. https://doi.org/10.1007/164_2017_33
Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, Mach RH (2000) Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 82(6):1223–1232. https://doi.org/10.1054/bjoc.1999.1067
Zeng C, McDonald ES, Mach RH (2017) Molecular probes for imaging the sigma-2 receptor: in vitro and in vivo imaging studies. Handb Exp Pharmacol. https://doi.org/10.1007/164_2016_96
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kim, F.J. (2017). Introduction to Sigma Proteins: Evolution of the Concept of Sigma Receptors. In: Kim, F., Pasternak, G. (eds) Sigma Proteins: Evolution of the Concept of Sigma Receptors. Handbook of Experimental Pharmacology, vol 244. Springer, Cham. https://doi.org/10.1007/164_2017_41
Download citation
DOI: https://doi.org/10.1007/164_2017_41
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65851-3
Online ISBN: 978-3-319-65853-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)